Russell Investments Group Ltd. Takes $1.39 Million Position in Grail, Inc. (NASDAQ:GRAL)

Russell Investments Group Ltd. bought a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 77,917 shares of the company's stock, valued at approximately $1,391,000. Russell Investments Group Ltd. owned about 0.23% of Grail at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Douglas Lane & Associates LLC purchased a new position in shares of Grail in the fourth quarter valued at about $3,034,000. A. D. Beadell Investment Counsel Inc. purchased a new stake in Grail in the 4th quarter worth approximately $430,000. FNY Investment Advisers LLC bought a new stake in shares of Grail in the 4th quarter worth approximately $26,000. 180 Wealth Advisors LLC bought a new stake in shares of Grail in the 4th quarter worth approximately $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management bought a new stake in Grail in the fourth quarter valued at $387,000.

Wall Street Analyst Weigh In

Several research analysts have commented on GRAL shares. Morgan Stanley upped their price objective on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th. Canaccord Genuity Group initiated coverage on shares of Grail in a research note on Monday. They issued a "buy" rating and a $32.00 price target for the company.

Insiders Place Their Bets

In other Grail news, President Joshua J. Ofman sold 2,109 shares of the business's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $65,800.80. Following the sale, the president now directly owns 559,673 shares of the company's stock, valued at approximately $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the sale, the chief financial officer now directly owns 335,170 shares in the company, valued at approximately $10,457,304. This represents a 0.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 11,550 shares of company stock worth $360,436.

Grail Price Performance

GRAL stock traded up $4.14 during midday trading on Wednesday, hitting $33.83. The stock had a trading volume of 1,987,123 shares, compared to its average volume of 1,225,341. The business has a 50-day moving average of $32.11 and a two-hundred day moving average of $23.85. Grail, Inc. has a 52-week low of $12.33 and a 52-week high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last released its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping analysts' consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analysts' expectations of $35.33 million. Research analysts expect that Grail, Inc. will post -15.15 EPS for the current fiscal year.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.